Literature DB >> 32737221

The atypical Rho GTPase RhoU interacts with intersectin-2 to regulate endosomal recycling pathways.

Olga Gubar1,2, Pauline Croisé1, Sergii Kropyvko2, Tetyana Gryaznova2, Petra Tóth1, Anne Blangy3, Nicolas Vitale1, Alla Rynditch2, Stéphane Gasman1, Stéphane Ory4.   

Abstract

Rho GTPases play a key role in various membrane trafficking processes. RhoU is an atypical small Rho GTPase related to Rac/Cdc42, which possesses unique N- and C-terminal domains that regulate its function and its subcellular localization. RhoU localizes at the plasma membrane, on endosomes and in cell adhesion structures where it governs cell signaling, differentiation and migration. However, despite its endomembrane localization, RhoU function in vesicular trafficking has been unexplored. Here, we identified intersectins (ITSNs) as new binding partners for RhoU and showed that the second PxxP motif at the N terminus of RhoU mediated interactions with the SH3 domains of ITSNs. To evaluate the function of RhoU and ITSNs in vesicular trafficking, we used fluorescent transferrin as a cargo for uptake experiments. We showed that silencing of either RhoU or ITSN2, but not ITSN1, increased transferrin accumulation in early endosomes, resulting from a defect in fast vesicle recycling. Concomitantly, RhoU and ITSN2 colocalized to a subset of Rab4-positive vesicles, suggesting that a RhoU-ITSN2 interaction may occur on fast recycling endosomes to regulate the fate of vesicular cargos.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Atypical Rho GTPases; Intersectins; Proline-rich domains; SH3 domains; Vesicle recycling

Mesh:

Substances:

Year:  2020        PMID: 32737221     DOI: 10.1242/jcs.234104

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  2 in total

1.  Longitudinal variation of circulating Inc-ITSN1-2: A novel biomarker reflecting disease severity, inflammation, recurrence, and death risk in acute ischemic stroke patients.

Authors:  Gang Wang; Ying Zhou; Tingting Zhong; Aixia Song; Qian Xue
Journal:  J Clin Lab Anal       Date:  2022-05-02       Impact factor: 3.124

2.  LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability.

Authors:  Lihua Ren; Xin Fang; Sachin Mulmi Shrestha; Qinghua Ji; Hui Ye; Yan Liang; Yang Liu; Yadong Feng; Jingwu Dong; Ruihua Shi
Journal:  Cell Mol Biol Lett       Date:  2022-10-11       Impact factor: 8.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.